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THE LANCET

COMMENTARY
Cultivation of Whipple bacillus: the irony and the ecstasy
For 90 years investigators (including George Whipple)
have been unable to propagate the microbe responsible
for Whipple’s disease, despite many published and
probably many more unpublished attempts.1 Evidence
that a bacterium causes Whipple’s disease has
accumulated in recent decades. Light and electron
microscopy show rod-shaped bacilli in the affected tissues
of these patients, usually free in the lamina propria of the
small bowel but also as partly degraded structures within
macrophage vacuoles.2 On the basis of histology,
investigators have suggested that these organisms
propagate extracellularly,3 although intact organisms have
been detected within several types of cells.4 A molecular
phylogenetic approach provides evidence that the Whipple
bacillus is a member of the actinomycete taxon of
bacteria.5,6 DNA from this microbe, unofficially named
Tropheryma whippelii, is almost invariably present in
patients who have Whipple’s disease, but disappears with
effective antibiotic treatment.7 Using both histological and
molecular data, G Schoedon and colleagues8 now provide
evidence of the successful propagation of T whippelii in
cell culture. Interleukin-4 (IL-4) was critical for rendering
peripheral blood monocytes and monoblastic cell-lines
permissive for intracellular growth of the organism.
It is ironic that the very cell believed to destroy the
Whipple bacillus has been used to nurture its replication
in the laboratory. This contradiction raises several new
questions about the bacillus and how it interacts with the
host. First, propagation of T whippelii within the artificial
environment created in the laboratory may have little
relevance to what occurs in natural infection. However,
successful laboratory cultivation of T whippelii in
macrophages suggests that some bacilli may survive and
replicate in vivo within the macrophages of patients. If
true, then the microbe may spread to other tissues as an
intracellular passenger, and the macrophage may serve as
a reservoir of infection, protecting T whippelii from
immune defences. Whipple’s disease is notable for a
disturbingly high rate of relapse despite months to years
of antibiotic treatment. Can the microbe persist within
macrophages of some patients, leading to subsequent
reactivation disease, in a manner analogous to
tuberculosis? On a more practical level, the in-vitro
propagation of T whippelii paves the way for much needed
antibiotic susceptibility testing, preparation of purified
antigens
for
serological
testing,
and
further
characterisation of this enigmatic microorganism.
Why is the laboratory propagation of T whippelii in
macrophages dependent on IL-4, and does this
requirement have clinical relevance? IL-4 promotes
differentiation of T cells towards a TH2 (helper)
phenotype, which leads to B-cell activation and
macrophage downregulation.9 By contrast, IL-2 promotes
differentiation towards a TH1 (inflammatory) phenotype,
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activating macrophages with γ-interferon and tumournecrosis factor. Is successful human infection with
T whippelii dependent on secretion of IL-4 and induction
of a macrophage-deactivating TH2 response? If
macrophages are deactivated, why do they seem to be
degrading bacilli under electronmicroscopy? If a TH2
response is needed for infection, is this response
determined by host genetic predisposition, or is it
orchestrated by the bacterium? Although an immune
defect has been postulated in patients with Whipple’s
disease, no specific defect has been described. The time is
now ripe for investigating abnormalities in cytokine
activity and T-cell differentiation in these patients.
Furthermore, the therapeutic use of macrophageactivating cytokines, such as γ-interferon and tumournecrosis factor, should undergo further testing. The
possibility remains, however, that patients with Whipple’s
disease have normal immune systems that are subverted
by T whippelii infection. Many microbes are known to
alter the usual host cytokine response to infection.
Epstein-Barr virus infection, for example, produces a
protein similar to IL-10 that promotes a TH2 response,10
and Yersinia enterocolitica blocks tumour-necrosis factor.11
It is not unreasonable to hypothesise that T whippelii may
also be capable of subverting the immune system by
promoting IL-4 release or blocking macrophage-activating
cytokines.
The approach used by Schoedon and colleagues offers
hope for the eventual in-vitro propagation of other
uncultivated or difficult-to-grow microbes, such as
Mycobacterium leprae and Treponema pallidum. The
expectation that all microbes can be propagated in pure
(lifeless or cell-free) culture has diminished with our
advancing knowledge of microbial ecology.12 In the
natural world, microbes tend not to exist as independent
homogeneous populations, but rather as interdependent
members of heterogeneous, complex communities
interacting with other prokaryotic and eukaryotic cells. If
we are to understand the microbial world that surrounds
and sometimes infects us, it is time for our cultivation
technology to move beyond the Petri dish to encompass
complex multicellular culture systems.
For almost a century, the scientific community has
awaited the successful cultivation of the Whipple bacillus.
Today, we eagerly await answers to old and new questions
about this microorganism and its mechanisms of
pathogenesis. Our enthusiasm is tempered only by a
patience wrought by 90 years of historical perspective.
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Genetic determination of bone density
An archaeological study of human skeletons from the 9th
to 16th centuries has recently revealed an association
between formation of bony osteophytes at joint margins
and formation of bony outgrowths at sites of insertion of
ligaments and tendons into bones (enthesophytes).1
J Rogers and colleagues therefore suggest that the
20–25% of skeletons that exhibit both osteophytes and
enthesophytes may reflect a group of individuals who can
be classified as “bone formers”.1
Many of the bone formers also had evidence of diffuse
idiopathic skeletal hyperostosis (DISH). Although the
aetiology of DISH is unknown, it is commoner in
individuals with diabetes mellitus than in the rest of the
population.2 DISH is also associated with heterotopic
ossification, the commonest complication of jointreplacement surgery.3 Rogers et al suggest that the
association between osteophytes, enthesophytes, and
DISH may reflect genetic differences between
individuals.1 Alternatively, the association may also reflect
a common mechanism of formation of these bone
outgrowths in response to mechanical forces and/or
diseases such as osteoarthritis or spondylarthropathies. In
support of the hypothesis that genetic differences may
account for variations in bone structure, twin and family
studies of modern individuals have shown that 60–80% of
the variation in bone density between individuals is
genetically determined.4,5 However, the genes that are
responsible for regulating bone density have not been
identified.
The candidate-gene approach has been used to
examine the effect of allelic variation in several genes that
are thought to play a role in normal bone homoeostasis.
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In this regard, the best-studied candidate gene encodes
the vitamin D receptor (VDR).
Although some studies have reported a strong
association between specific VDR alleles and bone
density, other studies have found no association.4–6 These
disparate results are most likely to be due to the different
genetic and environmental backgrounds in the cohorts
in which the VDR was studied. Several other candidate
genes that may regulate bone density, either
independently or in combination with the VDR, are listed
in the table.
An alternative to the candidate-gene approach is use of
linkage analysis to identify genes responsible for variations
in bone density between strains of mice7 or in human
Candidate genes for genetic determination of bone density
Gene

Type of studies

References

Receptors
Vitamin D receptor

Allele association

Reviewed in Eisman,4
Peacock,5 Ralston6
Reviewed in Ralston6
Reviewed in Korach et al.
Recent Prog Horm Res
1996; 51: 159–86
Cole et al. J Bone Miner Res
1997; 12 (S1): 257
Pollak et al. Cell 1993; 75:
1297–303
Masi et al. J Bone Miner Res
1997; 12 (S1): 257
Matkovic et al. J Bone Miner
Res 1997; 12 (S1): 257

Oestrogen receptor

Allele association
Gene mutation/
deletion

Calcium receptor

Allele association
Gene mutation

Calcitonin receptor

Allele association

␤3 adrenergic receptor

Allele association

Cytokines, hormones, and antagonists
Interleukin-6
Allele association
Gene deletion
Transforming growth factor␤ Allele association
Gene deletion/
overexpression

Insulin-like growth factor-I

Allele association

Parathyroid hormone

Allele association

Interleukin 1 receptor
antagonist

Allele association

Bone-matrix proteins
Type I collagen

Reviewed in Ralston6
Reviewed in Greenfield et al.
Cells Materials (in press)
Reviewed in Ralston6
Geiser et al. J Bone Miner
Res 1996; 11 (S1): S378;
Erlebacher et al. J Cell Biol
1996; 132: 195–210.
Hosoi et al. J Bone Miner
Res 1997; 12 (S1): 494
Hosoi et al. J Bone Miner Res
1997; 12 (S1): 494
Keen et al. J Bone Miner Res
1997; 12 (S1): 256

Osteocalcin
␣2HS glycoprotein

Allele association
Gene mutation
Gene deletion
Allele association

Reviewed in Ralston6
Reviewed in Ralston6
Reviewed in Ralston6
Dickson et al. Bone Miner
1994; 24: 181–88

Other
Apoprotein E

Allele association

HLA markers

Allele association

Shiroki et al. J Bone Miner
Res 1997; 12: 1438–45
Tsuji et al. J Bone Miner Res
1997; 12 (S1): 494

hereditary disorders. For example, the loci for both the
osteoporosis-pseudoglioma syndrome and a very high
bone mass trait have recently been linked to human
chromosome 11q12–13.8,9 Since these two disorders have
opposite effects on bone density, they may reflect
mutations in the same gene, with osteoporosispseudoglioma syndrome being an autosomal recessive
loss-of-function mutation and high bone mass being an
autosomal dominant gain-of-function mutation. Cloning
of the responsible gene(s) is likely to provide insight into
the processes that regulate bone density. Identifying the
genes that have the greatest impact in determining bone
density may lead to improved screening, diagnosis, and
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